Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Friedland

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2024
Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infectionKarl Reis, Allison Wolf, Rubeshan Perumal, et al.
BMC Infectious Diseases|May 1, 2026
Socio-ecological vulnerability subgroups predict adherence and treatment outcomes in multidrug-resistant tuberculosis and HIV: a latent class analysisKevin J Guzman, Allison Wolf, Rubeshan Perumal, et al.
The New England Journal of Medicine|February 26, 2010
Timing of initiation of antiretroviral drugs during tuberculosis therapySalim S Abdool Karim, Kogieleum Naidoo, Anneke Grobler, et al.
The New England Journal of Medicine|October 21, 2011
Integration of antiretroviral therapy with tuberculosis treatmentSalim S Abdool Karim, Kogieleum Naidoo, Anneke Grobler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2026
Characterizing the dual burden of stigma in people with multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in South Africa: A mixed methods, prospective cohort studyKarl Reis, Xuan Lu, Boitumelo Seepamore, et al.
Annals of Epidemiology|April 1, 2026
Early adherence predicts treatment outcomes and mortality in people living with HIV and multidrug-resistant tuberculosisKevin J Guzman, Rubeshan Perumal, Allison Wolf, et al.
Research Square|June 19, 2023
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): Study protocol for an adaptive randomized controlled trialJesse E Ross, Rubeshan Perumal, Allison Wolf, et al.
BMC Infectious Diseases|September 21, 2022
Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH)Jessica J Tuan, Heidi Zapata, Lydia Barakat, et al.
Trials|December 1, 2023
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trialJesse Ross, Rubeshan Perumal, Allison Wolf, et al.
AIDS (London, England)|November 26, 2019
Impact of early antiretroviral treatment on sexual behaviour: a randomised comparisonFiona C Lampe, Alison J Rodger, William Burman, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2024
Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infectionKarl Reis, Allison Wolf, Rubeshan Perumal, et al.
BMC Infectious Diseases|May 1, 2026
Socio-ecological vulnerability subgroups predict adherence and treatment outcomes in multidrug-resistant tuberculosis and HIV: a latent class analysisKevin J Guzman, Allison Wolf, Rubeshan Perumal, et al.
The New England Journal of Medicine|February 26, 2010
Timing of initiation of antiretroviral drugs during tuberculosis therapySalim S Abdool Karim, Kogieleum Naidoo, Anneke Grobler, et al.
The New England Journal of Medicine|October 21, 2011
Integration of antiretroviral therapy with tuberculosis treatmentSalim S Abdool Karim, Kogieleum Naidoo, Anneke Grobler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2026
Characterizing the dual burden of stigma in people with multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in South Africa: A mixed methods, prospective cohort studyKarl Reis, Xuan Lu, Boitumelo Seepamore, et al.
Annals of Epidemiology|April 1, 2026
Early adherence predicts treatment outcomes and mortality in people living with HIV and multidrug-resistant tuberculosisKevin J Guzman, Rubeshan Perumal, Allison Wolf, et al.
Research Square|June 19, 2023
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): Study protocol for an adaptive randomized controlled trialJesse E Ross, Rubeshan Perumal, Allison Wolf, et al.
BMC Infectious Diseases|September 21, 2022
Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH)Jessica J Tuan, Heidi Zapata, Lydia Barakat, et al.
Trials|December 1, 2023
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trialJesse Ross, Rubeshan Perumal, Allison Wolf, et al.
AIDS (London, England)|November 26, 2019
Impact of early antiretroviral treatment on sexual behaviour: a randomised comparisonFiona C Lampe, Alison J Rodger, William Burman, et al.
Pageof 11